By Dr Sarah Larney

Journal articles

Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J, 2018, 'Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57–63](S0376871618300140)(10.1016/j.drugalcdep.2017.11.023)', Drug and Alcohol Dependence, 186, pp. 9, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.005

Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L, 2018, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Pharmacoepidemiology and Drug Safety, 27, pp. 550 - 555, http://dx.doi.org/10.1002/pds.4329

Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J; Dolan K, 2018, 'Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study', International Journal of Drug Policy, 54, pp. 18 - 25, http://dx.doi.org/10.1016/j.drugpo.2017.12.013

Larance B; Gisev N; Cama E; Nelson EC; Darke S; Larney S; Degenhardt L, 2018, 'Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence', Drug and Alcohol Dependence

Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J, 2018, 'A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release', Drug and Alcohol Dependence, 184, pp. 57 - 63, http://dx.doi.org/10.1016/j.drugalcdep.2017.11.023

Nielsen S; Larney S; Farrell M, 2018, 'Commentary on McDonald et al. (2018): Intranasal naloxone—from the laboratory to the real world', Addiction, 113, pp. 494 - 495, http://dx.doi.org/10.1111/add.14087

Trickey A; Fraser H; Lim AG; Walker J; Peacock A; Colledge S; Leung J; Grebely J; Larney S; Degenhardt L; Hickman M; May M; Vickerman P, 2018, 'Comparing the prevention gains of different treatment strategies at the global, regional, and country level: a modelling study', Journal of Hepatology, 68, pp. S179 - S180, http://dx.doi.org/10.1016/s0168-8278(18)30571-3

Trickey A; Fraser H; Lim AG; Walker J; Peacock A; Colledge S; Leung J; Grebely J; Larney S; Degenhardt L; Hickman M; Vickerman P, 2018, 'The contribution of injecting drug use to Hepatitis C virus transmission globally, regionally, and at country level: a modelling study', Journal of Hepatology, 68, pp. S179 - S179, http://dx.doi.org/10.1016/s0168-8278(18)30570-1

Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S; Peacock A, 2017, 'Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review', The Lancet Global Health, 5, pp. e1192 - e1207, http://dx.doi.org/10.1016/S2214-109X(17)30375-3

Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L; Peacock A, 2017, 'Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review', The Lancet Global Health, 5, pp. e1208 - e1220, http://dx.doi.org/10.1016/S2214-109X(17)30373-X

Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S, 2017, 'Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances', Drug and Alcohol Dependence, 181, pp. 140 - 145, http://dx.doi.org/10.1016/j.drugalcdep.2017.09.026

Larney S; Farrell M, 2017, 'Prisoner suicide: a multilevel problem', The Lancet Psychiatry, 4, pp. 894 - 895, http://dx.doi.org/10.1016/S2215-0366(17)30435-2

Larney S; Hickman M; Guy R; Grebely J; Dore GJ; Gray RT; Day CA; Kimber J; Degenhardt L, 2017, 'Estimating the number of people who inject drugs in Australia', BMC Public Health, 17, pp. 757, http://dx.doi.org/10.1186/s12889-017-4785-7

Butler K; Day C; Sutherland R; van Buskirk J; Breen C; Burns L; Larney S, 2017, 'Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia', International Journal of Drug Policy, 47, pp. 102 - 106, http://dx.doi.org/10.1016/j.drugpo.2017.07.008

Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ, 2017, 'Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs', International Journal of Drug Policy, 47, pp. 51 - 60, http://dx.doi.org/10.1016/j.drugpo.2017.05.019

Horton M; McDonald R; Green TC; Nielsen S; Strang J; Degenhardt L; Larney S, 2017, 'A mapping review of take-home naloxone for people released from correctional settings', International Journal of Drug Policy, 46, pp. 7 - 16, http://dx.doi.org/10.1016/j.drugpo.2017.05.015

Hickman M; Grebely J; Bruneau J; Coffin P; Degenhardt L; Hutchinson S; Larney S; Martin N; Treloar C; Vickerman P, 2017, 'New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs—announcing an Addiction series', Addiction, 112, pp. 1126 - 1127, http://dx.doi.org/10.1111/add.13847

Larney S; Zador D; Sindicich N; Dolan K, 2017, 'A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia', Drug and Alcohol Review, 36, pp. 305 - 310, http://dx.doi.org/10.1111/dar.12442

Larney S; Peacock A; Mathers BM; Hickman M; Degenhardt L; Peacock A, 2017, 'A systematic review of injecting-related injury and disease among people who inject drugs', Drug and Alcohol Dependence, 171, pp. 39 - 49, http://dx.doi.org/10.1016/j.drugalcdep.2016.11.029

Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512

Alavi M; Amin J; Grebely J; Law MG; Janjua NZ; Krajden M; Hajarizadeh B; George J; Matthews GV; Larney S; Degenhardt L; Dore GJ, 2017, 'O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study', Journal of Virus Eradication, 3, pp. 9 - 9, http://dx.doi.org/10.1016/s2055-6640(20)30906-7

Cunningham E; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Hajarizadeh B; Dore GJ; Lloyd A; Grebely J, 2017, 'P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study', Journal of Virus Eradication, 3, pp. 15 - 16, http://dx.doi.org/10.1016/s2055-6640(20)30751-2

Larney S; Peacock A; Mathers BM; Degenhardt L, 2017, 'Systematic review and meta-analysis of injecting related injury and disease in people who inject drugs', Drug and Alcohol Dependence, 171, pp. e115 - e115, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.320

Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L, 2016, 'Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal', Addiction, 111, pp. 2177 - 2186, http://dx.doi.org/10.1111/add.13517

Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T, 2016, 'Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013', The Lancet Infectious Diseases, 16, pp. 1385 - 1398, http://dx.doi.org/10.1016/S1473-3099(16)30325-5

Larney S; Cama E; Nelson E; Larance B; Degenhardt L, 2016, 'A cross-sectional study of correlates of imprisonment in opioid-dependent men and women in New South Wales, Australia', Drug and Alcohol Review, 35, pp. 686 - 692, http://dx.doi.org/10.1111/dar.12357

Larney S; Lai W; Dolan K; Zador D, 2016, 'Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007–2013', Journal of Substance Abuse Treatment, 70, pp. 58 - 63, http://dx.doi.org/10.1016/j.jsat.2016.08.001

Butler K; Day CA; Burns L; Larney S, 2016, 'EXPANDING HEPATITIS C TESTING IN GENERAL PRACTICE FOR PEOPLE WHO INJECT DRUGS', DRUG AND ALCOHOL REVIEW, 35, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L, 2016, 'A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations', Annals of Epidemiology, 26, pp. 570 - 578.e2, http://dx.doi.org/10.1016/j.annepidem.2016.06.013

Degenhardt L; Larney S; Chan G; Dobbins T; Weier M; Roxburgh A; Hall WD; McKetin R, 2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', MEDICAL JOURNAL OF AUSTRALIA, 204, http://dx.doi.org/10.5694/mja15.00671

Larney S; Farrell M, 2016, 'Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisons', Addiction, 111, pp. 511 - 512, http://dx.doi.org/10.1111/add.13245

Larney S; Degenhardt L; Farrell M, 2016, 'Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths', Addiction, 111, pp. 560 - 561, http://dx.doi.org/10.1111/add.13208

Rich JD; McKenzie M; Larney S; Noska A; Clark J, 2016, 'Methadone for prisoners - Authors' reply', The Lancet, 387, pp. 225, http://dx.doi.org/10.1016/S0140-6736(16)00046-5

Rich JD; McKenzie M; Larney S; Noska A; Clark J, 2016, 'Methadone for prisoners Reply', LANCET, 387, pp. 225 - 225, http://dx.doi.org/10.1016/S0140-6736(16)00046-5

Mahowald MK; Larney S; Zaller ND; Scharff N; Taylor LE; Beckwith CG; Noska A; Rich JD; Flanigan TP, 2016, 'Characterizing the burden of hepatitis c infection among entrants to Pennsylvania state prisons, 2004 to 2012', Journal of Correctional Health Care, 22, pp. 41 - 45, http://dx.doi.org/10.1177/1078345815618384

Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026

Degenhardt L; Larney S; Chan G; Dobbins T; Weier M; Roxburgh A; Hall W; McKetin R, 2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', Medical Journal of Australia, 204, pp. 1.e1 - 1.e6, http://dx.doi.org/10.5694/mja15.00671

Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence', Addiction, 110, pp. 1975 - 1984, http://dx.doi.org/10.1111/add.13073

Gisev N; Shanahan M; Weatherburn D; Mattick RP; Larney S; Burns L; Degenhardt L, 2015, 'A COST-EFFECTIVENESS ANALYSIS OF OPIOID SUBSTITUTION THERAPY UPON RELEASE FROM PRISON', DRUG AND ALCOHOL REVIEW, 34, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Zador D; Sindicich N; Dolan K, 2015, 'PATIENT EXPERIENCES OF OPIOID SUBSTITUTION THERAPY IN PRISON: REASONS FOR SEEKING AND CEASING TREATMENT', DRUG AND ALCOHOL REVIEW, 34, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Grebely J; Hickman M; De Angelis D; Dore GJ; Degenhardt L, 2015, 'Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs', International Journal of Drug Policy, 26, pp. 950 - 957, http://dx.doi.org/10.1016/j.drugpo.2015.07.010

Kimber J; Larney S; Hickman M; Randall D; Degenhardt L, 2015, 'Mortality risk of opioid substitution therapy with methadone versus buprenorphine: A retrospective cohort study', The Lancet Psychiatry, 2, pp. 901 - 908, http://dx.doi.org/10.1016/S2215-0366(15)00366-1

Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L, 2015, 'A Cost-Effectiveness Analysis of Opioid Substitution Therapy upon Release in Reducing Mortality among Prisoners with a History of Opioid Dependence', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24, pp. 481 - 482, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980201134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Larney S; Gibson A; Kimber J; Burns L; Butler T; Mattick R; Weatherburn D; Degenhardt L, 2015, 'The Effect of Treatment and Retention with Opioid Substitution Therapy in Reducing Crime Among Opioid-Dependent People', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24, pp. 28 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Degenhardt L; Mattick RP; Farrell M, 2015, 'Variation in mortality risk of people released from prison', The Lancet Psychiatry, 2, pp. 681, http://dx.doi.org/10.1016/S2215-0366(15)00235-7

Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N, 2015, 'Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial', The Lancet, 386, pp. 350 - 359, http://dx.doi.org/10.1016/S0140-6736(14)62338-2

Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick RP; Butler T; Degenhardt L, 2015, 'Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study', Trends and Issues in Crime and Criminal Justice

Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L, 2015, 'A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia', Addiction, 110, pp. 646 - 655, http://dx.doi.org/10.1111/add.12834

Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic CM, 2015, 'Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study', Drug and Alcohol Dependence, 148, pp. 213 - 216, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.027

Larney S; Bohnert ASB; Ganoczy D; Ilgen MA; Hickman M; Blow FC; Degenhardt L, 2015, 'Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011', Drug and Alcohol Dependence, 147, pp. 32 - 37, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.019

Back to profile page